Trial NCT03761134

View at ClinicalTrials.gov 
Org. Study IDs: EFC15193
Secondary IDs: U1111-1195-6143

Last trial update was posted on 2022-04-25

MeSH Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol Metformin

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to transfer sponsorship during the conduct of ongoing studies.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID